Lianhua Technology (002250.SZ): Currently using the CDMO business model to provide customers with advanced intermediate products of chloramphenicol, only sold to this customer

Zhitongcaijing · 05/29 09:09

Zhitong Finance App News, Lianhua Technology (002250.SZ) issued an announcement. The cumulative deviation value of the closing price increase in the company's stock trading price for 3 consecutive trading days (May 27, 2025, May 29, 2025) exceeded 20%. According to the relevant provisions of the “Shenzhen Stock Exchange Stock Trading Rules”, this is a situation where stock trading fluctuates abnormally.

The company is concerned about recent public media reports relating to the company's involvement in the production of chloramphenicol. The company currently uses the CDMO business model to provide customers with advanced intermediates of chloramphenol. The company has a long-term partnership with the customer. The products are only sold to this customer, and the product pricing model is a cost addition. Up to now, the company has not received any notice from this customer regarding the increase in demand for related products. As a result, the impact of related matters on the company as a whole is limited. Other than the matters mentioned above, the company has found no recent public media reports that may or have had a significant impact on the company's stock trading price.

The company, controlling shareholders, and actual controllers have no important matters relating to the company that should be disclosed but not disclosed, or that are in the planning stage.